Abcentra LLC, a clinical-stage biopharmaceutical company, has named Timothy Wright, MD as its new director, it was reported on Wednesday.
Wright is the general partner at Time Bioventures and is a rheumatologist and drug developer. He has served in various senior leadership roles in research and development at Pfizer, Novartis, California Institute for Biomedical Research (Calibr/Scripps Research), and Regulus Therapeutics. He has served as chief of Rheumatology at the University of Pittsburgh.
Wright completed his MD, post-doctoral clinical, and research training at Johns Hopkins.
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign